1,325
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Perspective on animal models of dermatophytosis caused by Trichophyton rubrum

&
Pages 372-375 | Received 05 Mar 2015, Accepted 05 Mar 2015, Published online: 11 Jun 2015
This article is referred to by:
IL-1 signaling inhibits Trichophyton rubrum conidia development and modulates the IL-17 response in vivo

In this issue of Virulence, Yoshikawa et al.Citation1 described the role of the NLRP3 inflammasome in the response of macrophages to Trichophyton rubrum conidia, as well as the influence of interleukin-1 (IL-1) signaling in this interaction. On analyzing bone marrow-derived macrophages (BMDMs), the authors observed reduced IL-1β production in response to T. rubrum conidia in NLRP3−/−, ASC−/− and caspase-1/-11−/− cells. They also found that IL-1 signaling was important for delaying hyphal development in fungi, thereby protecting macrophages from destruction by the fungus. These findings yielded new and important perspectives for better understanding of the immunological aspects of T. rubrum infection. Although the authors did not provide in vitro evidence regarding which molecular fungal structures are involved with NLRP3 inflammasome activation, the study provides a novel point of view about this axis of immune responses triggered by T. rubrum infection. They used intraperitoneal infection with T. rubrum conidia and reported fungal recovery from the liver for IL-1R−/− and wild-type (WT) mice, but they did not find a statistical significant difference between the groups at any of the time points evaluated. Lower levels of IL-17 were observed for the IL-1R−/− group, leading the authors to suggest the involvement of this pathway in the in vivo infection by T. rubrum.The main concern about this in vivo model is the route of infection, since the occurrence of T. rubrum in deep organs, such as the liver and spleen, is not common, and also because of the lack of histopathological analysis of fungal infection in the liver tissue. This concern culminates in the great question yet to be answered: are the in vitro, ex vivo, and in vivo models of dermatophytosis caused by T. rubrum able to mimic the inflammatory response provided by the human skin against this fungus?

Trichophyton rubrum belongs to dermatophytes, a group of filamentous fungi that is composed of 3 genera: Epidermophyton, Microsporum, and Trichophyton. These organisms are also classified according to habitat, into anthropophilic, zoophilic, and geophilic fungi,2with Trichophyton rubrum being the most common etiologic agent of dermatophytosis.Citation3,4 Dermatophytes are known as keratinophilic fungi because of their predilection to infect keratinized tissues, e.g., skin, nail, hair, and horns,Citation2 implying that these tissues should be prioritized for the study of the host response. The clinical aspects of lesions are diversified and are a result of the delicate balance between the destruction of the keratin and the inflammatory response, which varies according to the etiologic agent and geographical localization.Citation5,6

Morphologically, T. rubrum may present hyaline hyphae, microconidia, and macroconidia in addition to chlamydoconidia and arthroconidia.Citation2,7 Moreover, all these components may be involved in the infection, and arthroconidia represent the main infective structure for humans. This unique characteristic of T. rubrum, associated with the fact that it is an anthropophilic fungus, is the first challenge faced by a researcher who wants to study the disease in an animal model. It is difficult to determine the number of viable structures for infection (mainly arthroconidia); therefore, most studies use microconidia as a standard fungal structure for infection of animals.Citation8,9 All these issues make the study of T. rubrum difficult and therefore only a small number of researchers have focused on the unknown aspects of fungus-host interactions.

Most animal models of dermatophytosis were obtained using zoophilic fungi, such as T. mentagrophytes or Microsporum canis, and guinea pigs are often the animal chosen.Citation10,11 Animal models using T. rubrum as the etiologic agent are scarce, and therefore little is known about the fungus-host interactions. Although the guinea pig model has many characteristics in common with human skin, work with guinea pigs has a few drawbacks, such as the difficulty in manipulating the animals and the necessity of a large space for cages (mostly because of the large size of the animal), as well as the most important drawback: the lack of knockout (KO) animals. In contrast, mice are easy to manipulate, are less time-consuming to study, and can be placed in small cages. Notwithstanding the fact that experimental infections on the backs of mice may lead to spontaneous healing in about 4 weeks or more after infection, mice are still a good choice as an animal model. Furthermore, it is easier to obtain KO animals with a mouse model. In this context, different studies support the use of mice for experimental dermatophytosis.Citation8,12,13 A previous study used T. quinckeanum to infect BALB/c mice, demonstrating pathological alterations and adherence of microconidia to keratinocytes within 4 hours of infection. In addition, early infiltration of neutrophils and formation of a mycelial mass (scutulum) in the epidermis were observed.Citation12 Venturini et al.Citation14 reported an invasive model of dermatophytosis involving T. mentagrophytes in Swiss mice. On performing subcutaneous injection into the footpad, the authors observed rapid spread of fungal cells to the popliteal lymph nodes, spleen, liver, and kidneys. In addition, the study showed a Th1-polarized immune response. Using a different approach, Nakamura et al.Citation13 established a mouse model of Trichophyton-induced contact hypersensitivity by using an extract from T. mentagrophytes and showed that mice mounted different inflammatory responses according to the immunological background. C57BL/6 mice presented not only Th1 but also Th17 cells; however, in BALB/c mice, thymic stromal lymphopoietin (TSLP) and IL-4 were enhanced after challenge. Although all these authors provided important details on the use of mice as an animal model, as well as suggested that these models may facilitate studies on the pathophysiology of Trichophyton infection, they all worked with zoophilic fungi. Overall, it is difficult to extrapolate the same findings to the context of infection caused by an anthropophilic fungus.

The inflammatory response triggered by infection with dermatophytes varies according to the fungal species. Usually, in the human host, anthropophilic fungi (e.g., T. rubrum) cause a weak inflammatory response; nevertheless, zoophilic and geophilic fungi, e.g., M. canis and M. gypseum, are related with a strong inflammatory response.Citation6 Observation of the adherence and invasion of host cells by the fungus have been performed mostly using in vitro or ex vivo approaches, as detailed in . However, while these approaches are very useful for elucidating some aspects of the fungus-host interaction, important questions about the immune response are still unanswered. This information reinforces the need for the development and characterization of models by using anthropophilic fungi, in order to improve the understanding of fungus-host interactions. From this point of view, Baltazar et al.Citation8 reported the successful use of mice as an animal model of dermatophytosis caused by T. rubrum. They showed that C57BL/6 WT mice presented high fungal burdens, mild dermatitis, and epidermal hyperplasia on the 7th day after infection. In addition, they reported the importance of the proinflammatory cytokines IL-12 and gamma interferon (IFN-γ) to control the infection, since IL-12−/− and IFN-γ−/− mice showed higher fungal burdens on the skin and lower IL-1β levels than the WT group. After establishing the model of dermatophytosis by T. rubrum, Baltazar et al.Citation15 and Gasparoto et al.Citation16 reinforced the reproducibility of the model, even using animals with different backgrounds, i.e., C57BL/6 and BALB/c mice, respectively. Baltazar et al.Citation15 treated T. rubrum infection with photodynamic therapy, demonstrating that diode emission at 630 nm and toluidine blue reduced the fungal burden in the skin compared to the level seen in the untreated control. In the same manner, Gasparoto et al.Citation16 showed that 2-(benzylideneamino)phenol (3A3), a new aldimine compound, was as efficient as itraconazole in reducing the fungal burden on the skin of mice, which is encouraging for future clinical investigations.

Table 1. In vitro and ex vivo models of infection with dermatophytes

Overall, significant efforts have been made toward a better understanding of the pathogenesis of dermatophytosis, but there are still a lot of gaps to be filled. For example, the models have shown that IFN-γ, IL-12, IL-1β, and IL-17 are important cytokines for controlling T. rubrum infection and that skin lesions of patients present lower expression of Toll-like receptor 4 (TLR4) than that seen in the control groups.Citation1,17,8 Furthermore, both dendritic cells (DCs) and macrophages interact with T. rubrum conidia,Citation8,9,18 but Santiago et al.Citation18 demonstrated that only DCs inhibited T. rubrum growth and induced Th activation, suggesting that these cells play an important role in coordinating the development of the cellular immune response during T. rubrum infection. In conclusion, much work is still required to provide scientific information about dermatophyte infections to a level at least similar to that for other fungal infections caused by species that are easier to manipulate (e.g., Candida and Cryptococcus).Citation19,20 The development of models specific for each dermatophyte species will provide valuable information regarding the dermatophyte-host relationship and will yield new perspectives to increase the understanding of its immunological and pathological aspects.

Disclosure of Potential Conflicts of Interest

No potential conflict of interest was disclosed.

Funding

LMB was supported by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). DAS is a research fellow of the Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq (grant 305154/2014–1).

References

  • Yoshikawa FSY, Gonçalves FL, Almeida SR. IL-1 signaling inhibits Trichophyton rubrum conidia development and modulates theIL-17 response in vivo.Virulence 2015.
  • Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev 1995; 8:240-59; PMID:7621400.
  • Peres NT, Maranhao FC, Rossi A, Martinez-Rossi NM. Dermatophytes: host-pathogen interaction and antifungal resistance. An Bras Dermatol 2010; 85:657-67; PMID:21152790; http://dx.doi.org/10.1590/S0365-05962010000500009.
  • Nenoff P, Kruger C, Ginter-Hanselmayer G, Tietz HJ. Mycology—an update. Part 1. Dermatomycoses: causative agents, epidemiology and pathogenesis. J Dtsch Dermatol Ges 2014; 12:188-209; quiz 10, 188-211; quiz 2.
  • El-Gohary M, van Zuuren EJ, Fedorowicz Z, Burgess H, Doney L, Stuart B, Moore M, Little P. Topical antifungal treatments for tinea cruris and tinea corporis. Cochrane Database Syst Rev 2014; 8:CD009992; PMID:25090020.
  • Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008; 51(Suppl 4):2-15; PMID:18783559; http://dx.doi.org/10.1111/j.1439-0507.2008.01606.x.
  • Esquenazi D, Alviano CS, de Souza W, Rozental S. The influence of surface carbohydrates during in vitro infection of mammalian cells by the dermatophyte Trichophyton rubrum. Res Microbiol 2004; 155:144-53; PMID:15059626; http://dx.doi.org/10.1016/j.resmic.2003.12.002.
  • Baltazar LM, Santos PC, Paula TP, Rachid MA, Cisalpino PS, Souza DG, Santos DA. IFN-gamma impairs Trichophyton rubrum proliferation in a murine model of dermatophytosis through the production of IL-1beta and reactive oxygen species. Med Mycol 2014; 52:293-302; http://dx.doi.org/10.1093/mmy/myt011.
  • Campos MR, Russo M, Gomes E, Almeida SR. Stimulation, inhibition and death of macrophages infected with Trichophyton rubrum. Microbes Infect 2006; 8:372-9; http://dx.doi.org/10.1016/j.micinf.2005.07.028.
  • Shimamura T, Kubota N, Shibuya K. Animal model of dermatophytosis. J Biomed Biotechnol 2012; 1-12.
  • Nakashima T, Nozawa A, Ito T, Majima T. Experimental tinea unguium model to assess topical antifungal agents using the infected human nail with dermatophyte in vitro. J Infect Chemother 2002; 8:331-5; PMID:12525893; http://dx.doi.org/10.1007/s10156-002-0192-8.
  • Hay RJ, Calderon RA, Mackenzie CD. Experimental dermatophytosis in mice: correlation between light and electron microscopic changes in primary, secondary and chronic infections. Br J Exp Pathol 1988; 69:703-16; PMID:3196658.
  • Nakamura T, Nishibu A, Yasoshima M, Tanoue C, Yoshida N, Hatta J, Miyamoto T, Nishii M, Yanagibashi T, Nagai Y, et al. Analysis of Trichophyton antigen-induced contact hypersensitivity in mouse. J Dermatol Sci 2012; 66:144-53; PMID:22459756; http://dx.doi.org/10.1016/j.jdermsci.2012.02.008.
  • Venturini J, Alvares AM, Camargo MR, Marchetti CM, Fraga-Silva TF, Luchini AC, Arruda MS. Dermatophyte-host relationship of a murine model of experimental invasive dermatophytosis. Microbes Infect 2012; 14:1144-51; http://dx.doi.org/10.1016/j.micinf.2012.07.014.
  • Baltazar LM, Werneck SM, Carneiro HC, Gouveia LF, de Paula TP, Byrro RM, Cunha Júnior AS, Soares BM, Ferreira MV, Souza DG, et al. Photodynamic therapy efficiently controls dermatophytosis caused by Trichophyton rubrum in a murine model. Br J Dermatol 2014; 172(3):801-4; http://dx.doi.org/10.1111/bjd.13494.
  • Gasparto AK, Baltazar LM, Gouveia LF, da Silva CM, Byrro RM, Rachid MA, da Silva Cunha Júnior A, de Resende-Stoianoff MA, de Fátima A, Santos DA. Two-(Benzylideneamino)phenol: apromising hydroxyaldimine with potent activity against dermatophytoses. Mycopathologia 2014; 179(3-4):243-51; http://dx.doi.org/10.1007/s11046-014-9850-5; PMID:25515245.
  • Oliveira CB, Vasconcellos C, Sakai-Valente NY, Sotto MN, Luiz FG, Belda Junior W, de Sousa Mda G, Benard G, Criado PR. Toll-like receptors (tlr) 2 and 4 expression of keratinocytes from patients with localized and disseminated dermatophytosis. Rev Inst Med Trop Sao Paulo 2015; 57:57-61; PMID:25651327; http://dx.doi.org/10.1590/S0036-46652015000100008.
  • Santiago K, Bomfim GF, Criado PR, Almeida SR. Monocyte-derived dendritic cells from patients with dermatophytosis restrict the growth of Trichophyton rubrum and induce CD4-T cell activation. PLoS One 2014; 9:e110879; PMID:25372145; http://dx.doi.org/10.1371/journal.pone.0110879.
  • Santos JR, Holanda RA, Frases S, Bravim M, Araujo Gde S, Santos PC, Costa MC, Ribeiro MJ, Ferreira GF, Baltazar LM, et al. Fluconazole alters the polysaccharide capsule of Cryptococcus gattii and leads to distinct behaviors in murine cryptococcosis. PLoS One 2014; 9:e112669; PMID:25392951; http://dx.doi.org/10.1371/journal.pone.0112669.
  • van de Veerdonk FL, Gresnigt MS, Oosting M, van der Meer JW, Joosten LA, Netea MG, Dinarello CA. Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37. Front Microbiol 2014; 5:762; PMID:25620965.
  • Esquenazi D, de Souza W, Alviano CS, Rozental S. The role of surface carbohydrates on the interaction of microconidia of Trichophyton mentagrophytes with epithelial cells. FEMS Immunol Med Microbiol 2003; 35:113-23; PMID:12628546; http://dx.doi.org/10.1016/S0928-8244(03)00007-5.
  • Yazdanparast SA, Barton RC. Arthroconidia production in Trichophyton rubrum and a new ex vivo model of onychomycosis. J Med Microbiol 2006; 55:1577-81; PMID:17030919; http://dx.doi.org/10.1099/jmm.0.46474-0.
  • Tani K, Adachi M, Nakamura Y, Kano R, Makimura K, Hasegawa A, Kanda N, Watanabe S. The effect of dermatophytes on cytokine production by human keratinocytes. Arch Dermatol Res 2007; 299:381-7; PMID:17710424; http://dx.doi.org/10.1007/s00403-007-0780-7.
  • Waldman A, Segal R, Berdicevsky I, Gilhar A. CD4+ and CD8+ T cells mediated direct cytotoxic effect against Trichophyton rubrum and Trichophyton mentagrophytes. Int J Dermatol 2010; 49:149-57; PMID:19968718; http://dx.doi.org/10.1111/j.1365-4632.2009.04222.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.